Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesAO12 is an ionizable cationic lipid that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA, circular RNA (circRNA), and single-guide RNA (sgRNA) in vitro and in vivo.1 It is a phenol-containing derivative of SM-102 (Item No. 33474) that reduces oxidative degradation of cargo mRNA and circRNA. LNPs containing AO12 accumulate in the liver. LNPs formulated with AO12 and encapsulating hepatocyte growth factor (HGF) mRNA reduce serum levels of alanine transaminase (ALT) and aspartate aminotransferase (AST) and decrease hepatic necrosis in a mouse model of acute liver injury induced by acetaminophen (Item No. 10024) or chronic liver fibrosis induced by carbon tetrachloride (CCl4). LNPs containing AO12 and encapsulating Cas9 mRNA and Nlrp3-targeting sgRNA reduce skin lesions, epidermal thickening, and skin tissue levels of IL-1β, IL-6, and TNF-α in a mouse model of psoriasis induced by imiquimod (IMQ; Item No. 14956).
WARNING This product is not for human or veterinary use.
1. Antioxidant lipid nanoparticles enhance mRNA stability for regeneration therapy and gene editing. Nat. Commun. 17(1), 7166 (2026).